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Abstract
Elderly Patient Adherence to Ocular Pharmaceuticals. Impact of Educational and
Physical Barriers
Lucky M. Wagner, M.S. Minnesota State University, Mantakto, May 2015

The purpose of this research was to assess and evaluate elderly patient’s attitudes
and behavior regarding educational and physical barriers and the impact on adherence to
ocular pharmaceuticals. A 19 question survey was developed and in order to collect data.
The survey was administered in person at the Edina Senior Center and the Burnsville
Senior Center and online via Zoomerang survey software regarding elderly patient
attitudes on educational and physical barriers and their impact on ocular pharmaceutical
adherence. Findings from this study indicate elderly patients treating an ocular condition
with ocular pharmaceuticals expressed strong agreement with improving upon both
educational and physical barriers as beneficial. Participants described their desire to
address both barriers with eye care providers and with the ocular pharmaceutical
products. Recommendations for further study included investigation of possible
interventions addressing the impact of educational and physical barriers to elderly patient
adherence to ocular pharmaceuticals. To conclude, health education professionals can
provide education strategies to elderly patients by integrating information regarding
educational and physical barriers to ocular pharmaceutical adherence by partnering with
eye care providers, other healthcare professionals dispensing ocular pharmaceuticals, and
the manufacturers of ocular pharmaceuticals.
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Chapter I: Introduction
Visual impairment is a common consequence of aging, according to the National
Eye Institute (n.d., para. 1) “as you age, you are at higher risk of developing age-related
eye diseases and conditions.” Age is considered a risk indicator for developing eye
diseases and conditions for the aging population. Furthermore, with increasing age
related vision diseases and conditions there is an increased use of pharmaceuticals as part
of ocular therapy. Wilson et al. (2007, p.7) report, “forty percent of older adults take five
or more prescription medications a day.” While the management of multiple medication
therapies is important, patient’s adherence to their prescribed ocular therapy is also
critical to the successful treatment of vision impairment or a vision related condition.
Medication adherence rates for ocular pharmaceuticals are considered low. According to
Wick (2012, para.1) these adherence rates drop “to between 50% and 80% within 6
months to a year.” Because of this low medication adherence rate, it is important to
consider how significant proper instillation of ocular pharmaceutics, such as eye drops, is
to treatment. Medication adherence affects the success and effectiveness of a patient’s
therapy.
The problem of failing to correctly self-administer ocular pharmaceuticals is a
substantial health care concern because non-adherence to ocular pharmaceutical therapy
is likely to result in negative consequences to the healthcare system and an individual’s
health. Chisholm-Burns and Spivey (2011, p. 826) discuss how the “consequences of non
adherence include worsening condition, increased comorbid diseases, increased health
care costs, and death.” These consequences of non-adherence can reduce the success of
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the prescribed ocular therapy in an individual. Poor medication adherence to ocular
pharmaceutical also burdens the healthcare system. Costs are compounded from wasted
medication, extra resources are needed to treat health complications related to failed
therapy, and the need to extend prolonged treatment of preventable failed therapy.
Statement of the Problem
Health educators must understand the educational and physical barriers
preventing the optimum utilization of eye drops. They must also understand how these
barriers affect adherence to prescribed ocular pharmaceutical therapy. A better
understanding of the impact of these barriers can improve patient care and success of
ocular therapy in elderly patients. Kass, Gordon, Morley, Meltzer, and Goldberg (1987)
explains that improving the understanding of the individual needs of the patients and their
difficulties with eye drops will lead to better adaptive patient care. Any deviation from
proper instillation of ocular pharmaceuticals can result in a decreased successful
treatment rate. Less than proper instillation of a medicated eye drop can negatively
impact the success of a prescribed ocular pharmaceutical therapy. The patient’s recovery
from a condition or illness is potentially slowed down, risk for relapse of the condition or
illness increases, or causes undue harm to the patient. As described by Marek and Antle
(2008, p.1), “many of the risk factors related to inadequate medication management are
items that are more prevalent in older adults living in the community.” Therefore, this
research study focuses on elderly persons aged 65 years and older who are particularly
susceptible and at high risk to these educational and physical barriers.
Educational barriers are potentially instructional pitfalls for elderly persons for
not understanding how to instill their prescribed eye drops correctly. Freda (2004)
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discussed how increasingly, however, appropriately intended comprehensive patient
education has become more difficult to accomplish. Instructional pitfalls include
directions that are difficult to follow, confusing terminology or word choice in the
directions, and a lack of visual or demonstrational guidance of how to correctly instill eye
drops. These instructional pitfalls are educational barriers that may impede an elderly
patient’s understanding of how to correctly use eye drops and instill the medication as
prescribed.
For this population of elderly patients, physical barriers to proper use of eye drops
include mechanical disadvantages. Burns and Mulley (1992) explain that the majority of
patients experienced some difficulty with the instillation of their drops. Some of these
mechanical disadvantages are the inability to see and read instructions and limitations in
capability to expel an eye drop from the container. It is important for health education
professionals to understand why these educational and physical barriers are significant
concerns to this study population. This knowledge permits health education professionals
to assist in the improvement of patient adherence rates and optimize the beneficial health
outcome elderly patients obtain from satisfactory adherence to ocular pharmaceuticals.
Significance of the Problem
From an ecological perspective, the problem of low patient adherence rate of
pharmaceuticals is rather large and expansive. At the community and social group levels,
the National Community Pharmacists Association (2013) estimates an added cost of $290
billion annually resulting from non-adherence to prescribed medication therapy. This is a
significant amount of money that could be returned to the healthcare system to mitigate
monies lost to fraud, waste, and abuse of medications. Repurposed monies associated
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with non-adherence to prescription medication could be used to improve healthcare
outcomes. At the individual level, non-adherence has significant and grave consequences.
According to Ho, Bryson, and Rumsfeld (2009, p.3029) “non-adherence causes
approximately 30 to 50% of treatment failures and 125,000 deaths annually.”
Understanding educational and physical barriers that impact medication non-adherence
can prevent these failures that cause harm, injury, and even death. It is evident from these
studies that this problem has substantial impact at the community and individual levels.
A review of the available literature reveals that ocular pharmaceuticals are an
under-assessed classification of medications for patient adherence rates. Therefore this
research study, which focuses on educational and physical barriers for proper instillation
of this class of medications, will add its observations and findings to the current health
education literature. Additionally, the outcomes of this research study have potential for
interdisciplinary use. Evaluating these two types of barriers can have translational
benefits. The survey instrument developed for this research study can be used for
subsequent study opportunities. The findings can be applied to other classes of
medications or pharmaceutical therapies. There are patient and provider education
materials, communication models, and potential intervention strategies that could be
implemented and incorporated into multiple therapy management plans to lessen the
impact of educational and physical barriers.
At multiple levels, from the community and social group to the individual, a
better understanding of how educational and physical barriers impact patient adherence
rates has the potential to improve health outcomes. These improvements could reduce

5
financial burden to health care system and progress patient’s health by maximizing the
health benefits from properly adhering to their prescribed ocular therapy.
Research Questions
1. For	
  elderly	
  patients,	
  how can the educational barrier of a lack of understanding
how to properly instill ocular pharmaceuticals be addressed and mitigated?
2. For	
  elderly	
  patients,	
  how can physical barriers be addressed to improve the
ability to properly self-administer eye drops as prescribed?
Limitations
Limitations of this research study include the following resource, participant, and
methodology limitations:
1. Limited time frame for research development.
2. Limited time frame for data collection.
3. Limited financial resources may limit the sample size.
4. Obtaining sufficient sample size for the findings to have practical statistical
significance.
5.

Reliance on participant self-report and self-admission to their own educational
or physical limitations.

6. Confidentiality agreements may also limit the sample size of the study.
7. Data collection will be gathered primarily through printed survey.
Delimitations
1. Sample population- Age restriction (elderly patients aged 65 years and older),
number of willing elderly patient participants, and identifying patients who are
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currently diagnosed with a condition requiring a prescribed ocular pharmaceutical
therapy.
2. Time frame- Time is defined by the researcher’s status as a graduate student
conducting a study in two 15-week academic semesters.
Assumptions
The main assumption of this research study is that significant portions of ocular
pharmaceutical (eye drop) users are elderly persons aged 65 years and older. This
assumption is appropriate for this research study because there is a relationship between
age and the number of prescribed medications for an individual. According to Hwang,
Weller, Ireys, and Anderson (2001, p.267) for seniors “Out-of-pocket spending for
prescription drugs was substantial.” An extension of this assumption is that a higher
proportion of older adults would also represent the larger portion of patients prescribed
eye drops for ocular pharmaceutical therapy.
Definition of Terms
The following terms and definitions are included in this research to serve in the
operational understanding of ocular pharmaceutical therapy. A pharmacy perspective of
healthcare is applied towards the research questions in this study.
•

Instillation: As defined by Hopper (2014, p. 144) as, “to place into; instructions
are commonly used for ophthalmic or otic drugs, as examples.”

•

Medication Adherence: The Agency for Healthcare Research and Quality defines,
(as cited in Centers for Disease Control and Prevention (CDC) 2013, presentation
slide 5) “the patients conformance with the provider’s recommendation with
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respect to timing, dosage, and frequency of medication –taking during the
prescribed length of time.”
•

Non-Adherence: Is defined by the American College of Preventative Medicine
(2011, para.3) as, “the extent to which a patient’s behavior (in terms of taking
medication, following a diet, modifying habits, or attending clinics) coincides
with medical or health advice.”

•

Ophthalmic Solutions: Are defined by the Aldrich and colleagues (2013, p.4) as,
“sterile solutions intended for instillation in the eye.”

•

Persistence: The Agency for Healthcare Research and Quality defines (as stated
by the CDC, 2013, presentation slide 5) as the, “duration of time patient takes
medication, from initiation to discontinuation of therapy.”
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Chapter II: Literature Review
Introduction
An appraisal of current professional literature found that there is a moderate
amount of research available about elderly patient adherence to prescribed medications.
There are fewer studies on patients who are using eye drops as part of ocular
pharmaceutical therapy. Studies that concentrate specifically on educational and physical
barriers impacting elderly patient adherence to prescribed ocular medications are even
more scant. This review of the literature related to this study’s research questions focus
on analyzing the information available on educational and physical barriers. This review
of the related literature is primarily an integrative literature review and approaches the
evaluation of educational and physical barriers with a pharmacy perspective to appraise
significant historical studies and recent research. A literature review matrix of the
literature reviewed for this thesis is available. (See appendix A).
This chapter concentrates on describing the educational and physical barriers and
reviewing studies designed to address and evaluate their impact on elderly patients
undergoing ocular pharmaceutical therapy. A discussion of recommendations from the
studies is also included. This integrated literature review of studies related to these two
barriers is critical because they strongly affect elderly patient adherence rates for ocular
pharmaceutical therapy. According to the National Eye Institute (n.d., para. 1) “as you
age, you are at higher risk of developing age-related eye diseases and conditions.” This
review centers on this elderly population because they are more likely than younger aged
persons to be treated with ocular pharmaceuticals for an ocular condition or disease.

9
A critical review and evaluation of the available literature is a form of best
practice, explained by Cottrell and McKenzie (2011, p.73) as “the concept of using
evidence that result from the critical review of multiple research and evaluation studies
that substantiate efficacy of an intervention in a certain population.” Evaluating the
history of research and works on these barriers connects previous works to the research
questions posed in this study. This review identifies how health education research
addressed educational and physical barriers that impact self-instillation of ocular
pharmaceuticals and affect elderly patient adherence rates.

Timeframe of literature reviewed
The timeframe of the literature reviewed is defined by the advent of ocular
pharmaceuticals to current date. Komatsu (2006) outlined the introduction of Federal
Drug Administration (FDA) approved ocular pharmaceutical drug classes as follows;
Pilocarpine preparations have been used since the 1870s. In the 1980s, beta-blockers
were developed. Then in 1999, prostaglandin-type ophthalmic preparations were
introduced to the drug market. This literature describes studies that focus on how
educational and physical barriers impact a specific administrative class of ocular
pharmaceuticals, that is, eye drops.

Structure and Organization
This literature review uses a parallel structure to describe both educational and
physical barriers and directs the audience through historical works to recent studies.
Pivotal studies are highlighted as they related to each barrier, elderly patient adherence
rates, and the success rates of self-instillation. A historical background demonstrates
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existing knowledge is available to address the research questions. It is important to show
the trajectory of where research began to where the health education field is today. This
also review emphasizes successes and failures in practice.

Health Education Theories and Models
This review of the existing literature and research studies found two prominent
theories related to educational and physical barriers impacting elderly patient adherence
of prescribed ocular pharmaceuticals- the Health Belief Model and Social Cognitive
Theory. Both older and newer health education research gave credit to this model and
theory. Rosenstock, Strecher, and Becker (1988) recognized that the Health Belief
Model, Social Cognitive Theory, self-efficacy, and locus of control have all been applied
with varying success to problems of explaining, predicting, and influencing behavior.
From this review of professional literatures the Health Belief Model and Social Cognitive
Theory has provided decades of strong support. I found this conclusion true, particularly
for patient adherence to medications.
Health Belief Model. The Health Belief Model is a tried and true model. It is
applicable to research about the educational and physical barriers impacting elderly
patient ocular pharmaceutical adherence rates. A concept from the Health Belief Model,
perceived barriers, lends itself to addressing research questions focused on barriers to
health outcomes. According to Janz and Becker (1984, p.556) perceived barriers “proved
to be the most powerful of the Health Belief Model dimensions across the various study
designs and behaviors.” This early work on perceived barriers is a significant component
of the Health Belief Model. The concept illuminated how important educational and
physical barriers are when factored into success of elderly patient adherence to eye drops.
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The Health Belief Model is a suitable choice to provide foundational support for this
research study.
Review of the literature also focused on the prominence of the Health Belief
Model. It continues to be recognized as an applicable model for researching the
contributing factors of elderly patient adherence to medications. Glanz, Rimer, and
Viswanath (2008, p.42) stated, “it is among the most widely applied theoretical
foundations for the study of health behavior change. The HBM is appealing and useful to
a wide range of professionals concerned with behavior change.” Seminal research studies
have used the Health Belief Model to design and evaluate interventions intended to alter
health behavior. This literature review found the model was applied to barriers impacting
elderly patient adherence of medication for a variety of health conditions, including but
not limited to chronic health conditions to specific illnesses such as diabetes and
glaucoma. Healthcare providers from various disciplines, covering a wide range of health
conditions and illnesses, offer prodigious support for the use of the Health Belief Model.
This model is appropriate as a theoretical basis for this research study on the educational
and physical barriers to elderly patient adherence to prescribed ocular therapy.
Social Cognitive Theory. The Social Cognitive Theory is a pivotal health
education theory reflected throughout the literature reviewed for this research study. This
theory has been used in multiple research studies and in interventions and programs
designed to mitigate the educational and physical barriers to elderly patient adherence to
medications. It was evident this theory serves as an appropriate foundation to support this
research study. Introduced in the 1980’s this theory has evolved in practice and grown in
favor amongst numerous health education research studies. Bandura (1988, p.276)
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presented the Social Cognitive Theory as, “a causal model where behavior, cognitive, and
other personal factors, and environmental events all operate as interacting determinates
that influence each other bi-directionally.” The Social Cognitive Theory and its focus on
determinant factors was an evident choice for researchers investigating influencing
factors on patient health behaviors. Examining these factors helped researchers
understand why non-adherence behaviors are observed.
This literature review discovered subsequent studies continued to rely on the
Social Cognitive Theory. Over a decade later, Bandura (2001, p.4) expanded upon the
Social Cognitive Theory by stating “these belief systems are a working model of the
world that enables people to achieve desired outcomes and avoid untoward ones.”
Research about the educational and physical barriers are individualized exercises that
impact patient adherence rates. Findings from this literature review helped to understand
how these barriers play an important role in these cognitive self-regulatory processes. In
the seminal study titled, “Patients' Beliefs about Prescribed Medicines and their Role in
Adherence to Treatment in Chronic Physical Illness,” Horne and Weinman (1999, p.560)
reported, “a relationship exists regarding patient beliefs about medicines to reported
adherence rates.” Higher necessity scores were linked with higher reported adherence
rates and higher concerns were linked to lower reported adherence rates. Longevity and
reliability is key to substantiating the use of this theory in health education research
studies related to the educational and physical barriers impacting elderly patient
adherence.
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Self-administering Medication in Elderly Patient Populations
Historical vantage points: patient-centered, provider- centered, and
concordance. Self-administering medication is a complex patient behavior. This
literature review found that studies are replete with attempts to observe, measure, or
explain this behavior. Until the philosophy of concordance arose in the early 2000’s there
was compliance and adherence to medications. Horne et al. (2005) describe two primary
vantage points found in the literature regarding the centricity of medication taking. These
vantage points are from the perspectives of the patient or the provider.
The term compliance has been used to describe the action of taking medication as
prescribed by the health care provider. However, the literature revealed that it is a
controversial term. Compliance suggests the patient is a passive responder to the
provider’s directions. Vlasnik, Aliotta, and DeLor (2005, p.48) explain this perspective
as, “adherence, formerly referred to as compliance, is a patient-centered term. It suggests
that patients carry out and maintain certain behaviors, such as taking medications, after
making an informed choice in a supportive environment.” Studies that focus primarily on
patient centricity, medication taking is in essence administering prescribed ocular
pharmaceuticals as instructed by the healthcare provider.
In contrast to patient centered research, is medication adherence from the
provider’s vantage. Adherence is considered a more suitable term because it recognizes
the patient as autonomous in their self-administration of medication. It also requires the
patient to agree to the directions given to them from the health care provider, by
recognizing the provider as having a larger role in the success or failure of a prescribed
ocular pharmaceutical therapy. The American College of Preventative Medicine (2011)
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suggests provider discussions help patients understand their illness and weigh the risks
and benefits of undergoing pharmaceutical treatment. Handbooks reviewed in this
literature review include, Medication Management of the Community-Dwelling Older
Adult. Patient Safety and Quality: An Evidence-Based Handbook for Nurses and Eye
Drop Adherence: Waste, Contamination, Inaccuracy’s Pharmacist’s Guide; which
demonstrated this perspective by delineating the roles and responsibilities of the eye care
provider when discussing pharmaceutical therapy plans.

Evolving from the compliance and adherence vantages of medication taking is the
philosophy of concordance. A formative work that addresses the provider and patient
relationship comes from Hughes (2004, p. 794), “Concordance represents a way in which
[the patient] can assume responsibility and contribute to decisions on healthcare,
particularly in relation to medications.” This can be thought of as a therapeutic agreement
between the patient and health care provider. Dowell, Jones, and Snadden (2002, p.31)
suggest that this “type of patient centered prescribing, focused on patients whose care is
sub-optimal, is likely to improve clinical outcomes as well as diffuse the issue of
adherence.” This literature review observed in the more recent studies that concordance is
the predominant vantage for focusing on the factors and / or barriers that impact patients
self-administering medication.

Despite the progression of medication adherence from a single perspective to a
collaborative one, medication adherence rates have remained stagnant. As reported by the
American College of Preventative Medicine (2011), rates of adherence have not changed
much in the last three decades, despite pushes from the World Health Organization
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(WHO) and Institute of Medicine (IOM) improvement goals.

Dimensions of medication adherence. A majority of the studies reviewed in this
literature review agreed upon the use of the World Health Organization’s five interacting
dimensions of medication adherence. Introduced in 2003, these dimensions include 1)
social/economic factors, 2) healthcare system, 3) medical condition-related factors, 4)
therapy-related factors, and 5) patient behaviors. The American Society on Aging and
American Society of Consultant Pharmacists Foundation (2006) addressed how these five
dimensions affect medication adherence. (See Figure 2.1.). In summary of these
dimensions, social and economic factors influence people to consider conflicting
priorities. Healthcare system factors affect knowledge, training and performance of the
health care team that includes the provider and patient as part of the system. Condition
related factors represent illness-related demands experienced by the patient. Therapy
related factors are unique characteristics of diseases and/or therapies. Patient behavior
factors consider physical factors, such as visual impairment and impaired dexterity, as
well as the resources, knowledge, attitudes, beliefs, perceptions and expectations of the
patient. The factors applicable to each dimension and can be translated to perceived
educational and physical barriers to using ocular pharmaceuticals.
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Figure 2.1. Five Dimensions of Medication Adherence

Figure 2.1. The five dimensions of medication adherence listing factors within
each dimension reported to affect adherence. From “Overview. Medication
Adherence- Where Are We Today?” by American Society on Aging and
American Society of Consultant Pharmacists Foundation, 2006, Adult
Meducation. Improving Medication Adherence in Older Adults, p. 13.
Copyright 2006 American Society on Aging and American Society of
Consultant Pharmacists Foundation.
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It is important to note that not every factor indicated was applicable to this
research study. A patient may have several risk factors for medication non-adherence and
that each dimension may impact the patient more or less severely than another dimension.
Self-administration. Many factors are considered for patients who are selfadministering their own eye drops to be considered adherent to their therapy. Nonadherence to medication can be considered either willful or inadvertent. There is a long
list of behaviors that account for non- adherence to medications. Exhibiting just one of
the following behaviors from this list considers the patient as non-adherent. The
American Society on Aging and American Society of Consultant Pharmacists Foundation
(2006) assembled a common list of behaviors associated with elderly patients. These
behaviors are applicable to drug classes, including eye drops:
•

Failing to initially fill a prescription

•

Failing to refill a prescription as directed

•

Omitting a dose or doses

•

Taking more or less of a medication than prescribed

•

Prematurely discontinuing medication

•

Taking a dose at the wrong time

•

Taking a medication prescribed for someone else

•

Taking a dose with prohibited other medications

•

Taking outdated medications

•

Taking damaged medications

•

Storing medications improperly

•

Using medication administration devices improperly
Predictors of non-adherence. Elderly patients' non-adherence to medication

regimens has the potential for negative health outcomes and far-reaching medical and

18
economic consequences. As Balkrishnan (1998, p.764) discussed, “as average life
expectancy increases, so do the incidence of chronic diseases and the number of persons
receiving long-term drug therapy.” Therefore preventing non-adherent behaviors is
important in the design of medication-management programs for this population.
Davis et al. (2006, p.849) recommends, “identification of older persons at risk for
medication non-adherence is just the first step in addressing this problem.” There are
warning signs of non-adherent behaviors of which healthcare providers and educators
must understand and be aware. Ho, Bryson, and Rumsfeld (2009) describe this awareness
and observation, although insensitive, of patient self-report of non-adherence is specific
enough and can predict future adverse outcomes. These signs of non-adherent behaviors
may not be obvious and health educators must be attentive to these signs.
Touchette and Shapiro (2008) identified common risk factors for poor medication
adherence, these are similar to risk factors reported by studies reviewed in this chapter
and listed as follows:
Educational predictors:
•

Low or limited language proficiency

•

Lack of belief in benefit of treatment

•

Inadequate follow-up or discharge therapy planning

•

Complexity of medication regimen

•

Side effects or fear of adverse reaction

•

Lack of insight into illness

Physical predictors:
•

Lower cognitive function
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•

Impaired physical limitation

•

Reduced dexterity

•

Substance abuse

Recommendations for study gaps
It is evident that medication adherence is a complex behavior that is strongly
influenced by multiple dimensions. The World Health Organization, (2003) suggests
medication adherence is related to patient knowledge and beliefs about their illness,
motivation to manage it, confidence in their ability to engage in illness-management
behaviors, and expectations regarding the outcome of treatment and the consequences of
poor adherence. Therefore, researchers would expect these influencing factors impacting
patient’s medication-taking behavior to change over time.
Two recommendations became apparent during this literature review; the need to
conduct multiple medication adherence assessments and to standardize the measurements
used in the assessment tools. Lee, et al. (2007) saw temporal changes in adherence
measures when assessed using general linear models for repeated measures. This study
highlights routine adherence assessments throughout a course of therapy.
Recommendations for future research to standardize medication adherence measurements
was suggested by multiple studies and emphasized by Morisky, Ang, Krousel-‐‑Wood, and
Ward (2008, p.348) who endorse this as a need for an “out-patient clinical settings need
for a valid, reliable, cost-effective tool that is accepted by both health care providers and
patients for measuring medication adherence.” For a better understanding of the
significance of medication non-adherence, future research should focus on these
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recommendations to standardize medication adherence measurements and use a
standardized assessment tool among the elderly.
Educational Barriers
Studies were reviewed for identification of educational barriers related to elderly
patients using eye drops as part of their ocular pharmaceutical treatment. This review
included a search of research and literature that focused on components including health
literacy, lack of language proficiency, and unproductive provider/patient communication
methods. Educational barriers to understanding how to correctly use medications as
prescribed by health care providers are a continuing problem facing patients, providers,
and health educators. Health literacy is a known issue, as Nkukuma Ngoh (2009, p.132)
states, “limited health literacy has been associated with poorer health, medication nonadherence, medication errors, higher medical expenses, and increased hospitalization.”
Similar observations were reported and reinforced these factors as a component of
educational barriers. Educational barriers negatively impact use of ocular
pharmaceuticals. Low literacy rates and a lack of language proficiency were identified as
predictors of medication non-adherence.

A review of the available literature reveals a minimal number of studies have
been conducted specifically on the impact of poor health literacy, lack of language
proficiency, and provider/patient communication methods for ocular pharmaceutical
therapy. Clifford, Barber, Elliott, Hartley, and Horne (2006) discuss the benefits from
improved communication when pharmacists are meeting patients’ needs for information
and advice on medicines. Seven studies identified in this review addressed educational
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barriers to glaucoma therapy. There is a lack of studies on educational barriers applicable
to eye drops in ocular pharmaceutical therapy outside of glaucoma-specified conditions.

A majority of studies reviewed for educational barriers that impact elderly patient
medication adherence relied on qualitative research methods to gather information on eye
drop users. The most commonly used tools were surveys, questionnaires, and in-depth
interviews. For a majority of tools used to measure adherence Garber, Nau, Erickson,
Aikens, and Lawrence (2004, p.649) suggest, “Questionnaires and diaries tend to have
moderate-to-high concordance with other measures of medication adherence.” However,
interview-based self-reports are not concordant with electronic measures. This
inconsistency found in assessment measurement was a common occurrence amongst
studies reviewed.

Similar analysis techniques were applied by studies assessing educational barriers.
The reported measurements were variable and unequivocal, thus making it incredibly
difficult to compare results from multiple studies. Hess, Raebel, Conner, and Malone
(2006) discussed how many measures used to assess adherence may or may not be
comparable or accurate. Not having a standardized measure or scale is a predicament
when trying to argue the importance of educational barriers. This is a discrepancy that
studies focused on performing systematic reviews stated needing to be addressed.
However, no study was identified having actually attempted to establish standardized
measurement for comparing the various studies.

The statistical results of research studies on educational barriers did not
demonstrate a range of values. Effect size of education barriers reported by various
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studies on the adherence rates was consistent. Peterson, Takiya, and Finley (2003)
indicate interventions focused on education barriers had an overall effect size effect size
of 0.11. The reported size effect of education barriers indicated no differences among the
different types of educational interventions researched.

Emerging from this review of available literature and studies on educational
barriers were recommendations for mitigation. Several studies suggested development of
a medication adherence model to guide healthcare providers. According to National
Council on Patient Information and Education (2007, p.1) “to achieve the awareness,
behavior changes, and additional resources for research and education that will improve
patient medication adherence requires an ongoing partnership.” The purpose of
developing a medication adherence model is to reduce the impact of education barriers on
patient adherence to ocular pharmaceuticals. There is advocacy for educational strategies
focused on patient behaviors. Addressing educational barriers through opportunities to
engage providers and patients is a two- pronged approach to improving medication
adherence. This review of the professional literature observed the Medication Adherence
Model and the SIMPLE method as two influential works prominent in discussions
regarding educational barriers.

The Medication Adherence Model was developed to describe the process of
medication adherence and instruct health care providers in a systematic method of
assessing medication taking. Johnson (2002) suggests the model is structured with the
idea that two types of non-adherence contribute to inconsistent medication taking. The
first type of non-adherence is the intentional decision to miss medications. The second
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type is unintentional interruptions that cause medications not to be taken. This model
allows providers with an opening to evaluate these two types of non-adherence. Providers
could also measure significance and overall effect of education barriers on ocular
pharmaceutical adherence. Providers can parlay the results and use them in the treatment
plan. These two types on non-adherence factors are employable as measurable indicators
of ocular pharmaceutical adherence.

The SIMPLE method is an educational strategy to improve medication adherence.
According to Atreja et al. (2005, p. 4) it stands for S-simplify regimen, I-impart
knowledge, M-modify patient beliefs and human behavior, P-provide communication and
trust, L-leave the bias, and E-evaluate adherence. There is an abundance of support
behind the SIMPLE method because it focuses on patient education. However, the
method recognizes that education strategies must be paired with a simple regimen and
effective provider/patient communication to modify medication adherence behaviors.
This prominent study recommended promising strategies for providers and for patients to
alleviate educational barriers.

Physical Barriers
This literature review found few research studies that focused on addressing
physical barriers and how patients perceive physical capability as a function of adherence
to therapy. Winfield, Jessiman, Williams, and Esakowitz (1990) explain their results
indicated a high prevalence of non-compliance was compounded by inabilities to
adequately instill a drop into the eye. Studies dedicated exclusively to researching
physical barriers to ocular pharmaceutical instillation were few. Physical factors are a
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patient related dimension of patient adherence. Examples of physical components that are
barriers to correctly instilling eye drops are vision loss, cognitive ability, and factors such
as impaired mobility or dexterity.

Studies reviewed noted safety issues associated with vision loss. Low vision and
blindness affect a person's ability to read prescription labels and information sheets about
medications, distinguish colors and markings identifying a medication, and see
measurement gauges on devices and tools. Elderly patients who cannot see and read
prescription labels must rely on memory when self-administering eye drops. A physical
risk for patients with low vision or vision loss is a physical condition. These are physical
barriers for patients not taking their medications correctly or at all.

Cognitive factors include physical and neurological impairment components such
as memory loss. Salzman (1995) noted that forgetting to take a medication is a common
problem in older people. This is reported as the most common barrier hindering the
elderly when taking medications. Not instilling ocular pharmaceuticals correctly and
timely due to forgetfulness is a non-adherent behavior associated with physical barriers.

The last physical barrier related to elderly patients adherence to their ocular
therapy is impaired motility and dexterity. These are specific physical barriers that may
make it difficult for a patient to accurately instill or measure a dose. In the case of ocular
pharmaceutics, a patient with impaired mobility or dexterity may be unable to position
the eye dropper tip, apply enough pressure to the container to expel an eye drop, or instill
the eye drop with enough precision into the eye’s conjunctiva sac.
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The small portion of studies in this literature review that focused on physical
barriers relied on qualitative research techniques to gather information on eye drop users.
The studies assessing this barrier used similar instruments to collect data. Surveys,
questionnaires, and observing instillation demonstrations were the main qualitative
research instruments reported in the available studies.

Researchers from studies available applied similar analysis techniques to assess
the impact of physical barriers on eye drop medication adherence. The reported
measurements were variable and unequivocal, thus making it very difficult to compare
results from one study to another. Similar to studies on education barriers, not having a
standardized measure or scale is a quandary. Health educators need reliable
measurements to emphasize the importance of minimizing physical barriers. The
literature reveals studies focused on performing systematic reviews have acknowledged
this discrepancy in reported measurements. To date, no study has tried to establish a
standardized measurement guideline for evaluating physical barriers.

The statistical analysis of data on physical barriers demonstrated a stronger effect
size on medication adherence. Morisky, Green, and Levine (1986) reviewed the
psychometric properties to test the concurrent and predictive validity of a structured fouritem self-reported adherence measure. Items in this scale address physical barriers to
medication taking, however, the scale is not specific to ocular pharmaceuticals. A
stronger measure warrants the health care provider to reinforce positive medication
adherence behaviors. However, with so few studies to report findings of the effect of
physical barriers on medication adherence, there is a problem due to this lack of support
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for a consensus of statistical significance.

In the literature reviewed, three types of recommendations were found to help
elderly patients overcome physical barriers and instill eye drops. This was emphasized by
Tsai, Robin, and Smith (2007, p.29) as “an important factor that is often overlooked is the
method of eye drop administration, including the handling, storing, and actual
administering of eye drops.” Strategies for minimizing physical barriers involve selfadministering eye drops in optimal environmental conditions, the use of alternative label
formats for elderly persons with visual impairment and the use devices to improve
patients physical capability to instill the correctly into the conjunctiva sac with the correct
number of drops and accurate dosage.

Optimal physical environment that promotes accurate medication use include five
key areas—1) illumination, 2) minimizing interruptions and distractions, 3) reducing
sound and noise, 4) considering physical design and organization, and 5) designating
medication safety zones. These ideal environmental conditions are recommended by
Grissinger (2012) to minimize distractions for an elderly patient. When possible
instillation should be performed in ideal settings that accommodate these five key areas
conducive to correct eye drop instillation.

The American Society on Aging and American Society of Consultant Pharmacists
Foundation (2006) recommends the use of alternative label formats and devices for
elderly persons with visual impairment to help overcome physical barriers.
Recommendations from the American Society on Aging and American Society of
Consultant Pharmacists Foundation (2006) also include:
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o Asking the person if he or she needs help and what would be useful
o Using large print on labels and written materials (minimum 16 point)
o Using black ink on light background (high contrast) for written materials
o Avoiding materials that reflect light or cause glare
o Providing large print duplicate prescription label
o Giving clear verbal instructions
o Using color coding on medication containers (if patient can detect color) or
different color labels on the bottles to indicate when to take medications
o Using electronic dispensing devices with an alarm when dose is due
o Using magnifying device
o Encouraging improved lighting where medications are stored and taken
o Using aids or tools to assist in instilling ocular pharmaceuticals (American
Society on Aging and American Society of Consultant Pharmacists Foundation,
2006).

The use of mechanical aids can be helpful to elderly patients to overcome
physical barriers to instilling eye drops. These devices are designed to assist the patient
overcome various physical barriers. Corlett (1996) described the following trade-name
eye drop devices: Opticare, Autosqueeze, and Autodrop. Eye drop devices aid in
positioning the eye drop, so instillation is performed correctly. The eyedropper tip is
aimed with precision into the conjunctiva sac. Additionally, these aids help to enhance
the physical strength of a patient to squeeze the correct size eye drop from the bottle.
Drop size is important because too large or small of a drop is a variability in dosage.
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Gaps in the Literature
Three main gaps were found in the literature available on education and physical
behaviors that impact elderly patient adherence to ocular pharmaceutics. The available
studies in this literature review did not explain in great detail these potential barriers to
medication adherence. They did not necessarily focused on patients undergoing ocular
pharmaceutical treatment. Lastly, there was a clear limitation of the data available.
Although there is a moderate amount of information and research completed on
medication adherence, these particular barriers to correct usage are not well described.
Gellad, Grenard, andMarcum (2011, p.11) summarized this observation well,
“medication non-adherence in the elderly is not well described in the literature, despite
being a major cause of morbidity, and thus it is difficult to draw a systematic conclusion
on potential barriers based on the current literature.” Most of the recent studies
recommend further research or investigation into the additional potential factors that
contribute to education or physical barriers. However, to date, this literature review found
the education and physical barriers impacting the dimensions of medication adherence
under-evaluated.
In addition to detecting studies that under-evaluated barriers to medication
adherence, only two studies actually recommended findings that were translational to
ocular pharmaceuticals. Notably, most of the studies related to ocular pharmaceuticals
were tied to glaucoma diagnosis and therapy. This literature review found seven studies
focused on ocular pharmaceutical treatments for glaucoma. A total of five studies focused
specifically of educational or physical barriers and the impact on patient medication
adherence to ocular pharmaceutical therapy. This literature review search found three
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studies focused explicitly on education barriers to patient adherence to ocular
pharmaceutical therapy. Only two studies focused on exactly on the physical barriers
impacting patient adherence to ocular pharmaceutical therapy. This scarce number of
available studies demonstrated just how under-evaluated this class of pharmaceuticals is
in health education literature.
The data available, through literature database searches, for this literature review
was also limited. In order to assess the available literature for the research questions
required independent searches of the key words: elderly patients, medication adherence,
educational and physical barriers, and ocular pharmaceuticals. Refining the database
search to find studies that focused explicitly on the research questions required connected
searches (linked Boolean method) of these same key words. The databases searched
included Ageline, BioMedCentral, Cochrane Plus Collection, MEDLINE, and
ScienceDirect. This literature review revealed that very limited data has been collected
that comprehensively addressed elderly patients, medication adherence, educational and
physical barriers, and ocular pharmaceuticals. Inadequate available data collected on
ocular pharmaceutical therapy was an issue. Mojtabai and Olfson (2003, p.228) highlight
the problem with limited data and argued that, “despite widespread public attention to
this issue, little information exists concerning the use of medications and health outcomes
among Medicare beneficiaries without prescription drug coverage.” Data on elderly
patients relies heavily on prescription claims data. In the United States potential sources
of raw medication data comes from Medicare information. A majority of the studies
reviewed collected data from surveys, interviews, and interventions, but also made use of
claims data, referenced in their methodology.
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Summary
Low medication adherence rates to ocular pharmaceuticals continue to be a
problem in health education. The historical perspectives of medication taking were either
from a patient-centered vantage or a provider vantage point. Perspectives then
transitioned the focus of medicine taking from compliance, to adherence, and most
recently concordance. More recent studies focus on concordance, where a patient and
provider agreement on ocular pharmaceutical therapy. This integrative literature review
considered the available works and selected featured studies and key research conducted
on elderly patient adherence to instilling ocular pharmaceutical medication.
The emphasis of this review was on the impact of educational and physical
barriers to correct eye drop instillation in elderly populations. Educational and physical
barriers played a large part in patient adherence to their prescribed ocular pharmaceutical
therapy. This review of related literature describes how previous and current studies have
investigated the problem of educational and physical barriers and evaluates programs for
their success or failure in improving patient adherence rates. Educational
recommendations aligned with these by Okeke, et al. (2009) are understanding
educational efforts to improve patient drop taking played an important role in improving
patient adherence. These included instruction on proper administration of eye drops,
correct dosing schedules, minimization of waste of medication, and a clear discussion
that vision can be lost if the medications are not used properly. Strategies to minimize
education barriers integrates an agreed upon provider/patient ocular pharmaceutical
therapy. The strategies include a two pronged approached to address health literacy and
lack of language proficiency. Suggestions from studies reviewed to lessen the negative
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impact of physical barriers such as Lacey, Cate, and Broadway (2009) emphasized
common recommendations to improve the operational and technique issues as the main
areas of physical barrier concerns to mediation adherence. These recommendations
included optimizing environmental conditions, advocating for alternative label formats,
and suggesting the use of eye drop instillation tools or aids to express eye drop solution
into the eye. For both education and physical barriers standardized measurement is
encouraged to increase validity and reliability of patient adherence assessments.
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Chapter III: Methodology
Introduction
The purpose of this research was to assess and evaluate elderly patients’ attitudes
and behavior about educational and physical barriers and the impact on adherence to
ocular pharmaceuticals. This chapter describes the research design of this study and
selection of eligible participants, survey instrument, data collection, data analysis, and
pilot test used to gather data. The Minnesota State University, Mankato Institutional
Review Board (IRB) was approved the study proposal on February 24, 2015. (See
Appendix B).
Research Questions
1. For elderly patients, how can the educational barrier of a lack of understanding of
how to properly instill ocular pharmaceuticals be addressed and improved upon?
2. For elderly patients, how can physical barriers be addressed to improve the ability
to properly self-administer eye drops as prescribed?
Research Design
This thesis research is designed as a one-time cross sectional study. The
methodologies employed are quantitative research techniques. Data were collected using
a survey instrument that included an open response portion to three questions. The
following sections describe the methods selected for inclusion criteria, instrumentation,
and procedure. Descriptions of the qualitative and statistical analysis for this research
study are also included.
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Inclusion criteria. Inclusion criteria for participants in this study were very
particular. To address how educational and physical barriers impact patient adherence to
eye drops requires specific criteria based upon age, diagnosis, and treatment. The
inclusion criteria for this research study are:
1. The participant must be aged 65 years or older.
2. The participant must be diagnosed with an eye disease, condition, or illness.
3. The participant is currently under going ocular pharmaceutical treatment with eye
drops at the time of data collection.
This research study used homogenous sampling procedures to find participants for
this study population. According to Cottrell and McKenzie (2011, p.132) homogenous
sampling procedures “includes individuals chosen because of a unique trait or factor they
posses.” The unique trait in this study is a participant is selected because she/he possesses
a unique diagnosis requiring treatment with eye drops. Homogenous sampling procedure
is appropriate for this study because of the difficulty in identifying participants with a
specific health condition and treatment approach and identifying an acceptable number of
eligible participants.
Instrument consideration. When studying subjects who are currently
undergoing ocular pharmaceutical therapy, the survey instrument must consider
addressing areas of concerns that include private health information and confidentiality.
The in-person and online consent forms explained the purpose of this study and a form
was included with every survey instrument. (See Appendix C and Appendix D). To
safeguard the patient’s private heath information and confidentiality, participants are not
asked to include their name on the survey instrument. Additionally, the survey does not

34
focus on demographic questions that could identify a participant. The two demographic
questions included in the survey instrument are participant age and gender.
Instrument design. Instrument design required incorporating the participant
inclusion criteria questions into the survey. This allows the researchers to easily identify
which participants were eligible. Using inclusion criteria as survey questions ensures the
data collected is relevant to answering the questions asked in this study.
The survey instrument format began with a statutory question set that included
general demographic questions and inclusion criteria questions. These statutory questions
were designed to identify eligible participants. The survey questions focused on
addressing the educational and physical barriers of instilling eye drops will collect data to
support the operational constructs. These Likert-scale questions identify levels of
agreement about educational and physical barriers. The survey instrument format ended
with open-response questions. This question type provided participants with an
opportunity to share qualitative details regarding their ocular pharmaceutical experience.
The survey instrument design utilized statutory, Likert-scale, and open response
questions to gather a wide breadth of data. Data collected from this instrument are
directly pertinent to the research questions and help in understanding the impact of
educational and physical barriers on patient adherence to their prescribed eye drop
therapy.
Validity and Reliability
Validity. The researcher developed the survey instrument for use in this thesis
study. To ensure content validity of the survey instrument, the survey questions were
written with the advisement of two pharmacist advisors. (See Appendix E). Conferring

35
with professionals from the pharmaceutical field of work supports the validity of the
survey questions. The survey questions were designed to gather information and data
related to the research questions. This additionally ensured the questions were written
with a pharmacy perspective and maintained the continuity of this thesis study within
scope of ocular pharmaceutical therapy.
Reliability. Reliability measures were integrated into the survey instrument.
There is only one version of the survey instrument. Using only one version of the survey
ensured each participant was exposed to the same questions. This addressed measurement
consistency because using one version of the survey instrument elicited the same type of
responses from the same questions.
Pilot Test
A group of four people who met inclusion criteria were asked by the student
researcher to test the survey instrument. It was administered as described for in-person
survey takers. The feedback collected was used to improve its design. Regarding the
procedure the pilot test group made the recommendation that the researcher should be
available for questions. An observation noted about survey administration was the time to
complete the survey questions was actually less than the five minutes stated on the
consent form. Feedback collected about the survey instrument was also gathered. The
pilot test group recommended larger font. This recommendation was used and the survey
font-size was increased. The pilot test group also suggested that the Likert-type
education/instruction questions could be more concise. The changes collected from the
pilot test group were incorporated in the final survey instrument used for this study.
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Data Collection Process
Research design description. This study used a conjugated research design to
gather data and answer the two research questions. The design used both a quantitative
and qualitative data collection techniques. The survey questions gathered responses from
participants about their perception of educational and physical barriers. Participants could
also provide responses regarding the impact of these barriers on their adherence to their
prescribed ocular therapy. The narratives provided to the open response questions gave
in-depth and detailed information about experiences and offered perspectives on
undergoing prescribed ocular pharmaceutical therapy.
Survey administration procedure. Prior to distributing the survey instrument,
the researcher obtained approval from Minnesota State University, Mankato IRB to
conduct research on human subjects.
The survey instrument was distributed in-person and electronically. In-person
events were conducted at local Minneapolis area senior centers. Written permission was
granted by the Edina Senior Center (See Appendix F) and by the Burnsville Senior
Center (See Appendix G). A table set up was arranged to offer the surveys to persons
who visited the community center on March 3, 2015 and March 10, 2015. With each
encounter, the researcher explained the purpose of the study before asking a person to
take a survey. Before a survey was taken the consent form was offered. It was read aloud,
when requested. Then a signature was collected prior to the survey questions being
answered. When the participant completed the survey, it was collected and placed in an
envelope. The researcher offered the participant a copy of the consent form. Lastly and
equivocally important was that participants were thanked for their time.

37
Electronic distribution of the survey was conducted using the online survey
administrative tool, Zoomerang ™. The researcher set up a user account with
administrative rights that established distribution controls. These controls included
defining the inclusion criteria to target eligible survey participants. Zoomerang ™
allowed the researcher to define who the potential respondents were by restricting the
respondent pool. The criteria entered into the Zoomerang ™ database to target an
audience for this survey were age and treatment. After the researcher defined the target
audience, an electronic version of the consent form and survey was distributed to the
target audience email lists. The respondents were required to indicate they had received
the consent. Requiring the consent form to be acknowledged prior to beginning the actual
survey is an administrative control. Another administrative control in place was the
timeframe for administering and collecting surveys; approximately two-weeks between
February 25, 2015 to March 11, 2015. As surveys were completed, Zoomerang ™
securely cached the surveys for the researcher.
Analysis of Data
The data analysis procedure used for this research study was descriptive statistics.
Analysis of the quantitative data collected from the survey was completed using the SPSS
analytical tool. The table of specifications lists how each survey question tied directly to
the research questions asked in this thesis study. (See table 3.1). The research questions
were designed to collect interval, nominal, and ordinal data. The data were analyzed with
descriptive statistical analysis to evaluate the frequency and percentage of responses.
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Table 3.1
Table of Specifications
Research Question
(RQ)
1.

How can the
educational
barrier of a lack
of understanding
how to properly
instill ocular
pharmaceuticals
be addressed and
mitigated?

Survey items or methods used
to assess RQ’S
What is your eye condition?

Level of Data
(Nominal,
Ordinal,
Interval/Ratio)*
Nominal

Analysis
needed to
assess RQ
Frequency,
Percentage

How long have you been using
eye drops to treat your eye
condition?

Interval

Frequency,
Percentage

How frequently do you see your
Optometrist or Ophthalmologist?
- Never
- 1time each year
- 2 to 3 times each year
- More than 4 times each year

Ordinal

Frequency,
Percentage

Who provides you with
instructions on how to use your
eye drops?
- Optometrist or
Ophthalmologist
- General or Primary Physician
- Physicians’ assistant
- Nurse
- Pharmacist
- Other: Please, describe _____
- No one

Nominal

Frequency,
Percentage

How many eye drops are lost
and do not make it into your
eye(s) per dose?
- No drops are lost per dose
- 1 to 2 drops are lost per dose
- 3 to 4 drops are lost per dose
- More than 5 drops are lost per
dose

Ordinal

Frequency,
Percentage
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Table 3.1
Table of Specifications
How many eye drops do you use
to treat your eye condition?
- One
- Two
- Three or more

Ordinal

How long have you been using
your eye drops to treat your eye
condition?
- Less than 1 week
- 1 to 2 weeks
- 3 or more weeks

Frequency,
Percentage

Frequency,
Percentage

Instructions on how to use your
eye drops are easy to follow.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage

Word choice to explain
instructions is clear to
understand how to use your eye
drops.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage

Using pictures to illustrate
instructions for how to use your
eye drops would improve your
understanding of how to use
them.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage
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Table 3.1
Table of Specifications

2.

How can the
physical barriers
be addressed to
improve the
ability to
properly instill
prescribed eye
drops?

Using video instructions to
demonstrate the instructions for
how to use your eye drops would
improve your understanding of
how to use them.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage

What do you believe are
educational barriers to effective
use? In your opinion, how could
the instructions for your eye
drops be improved?

Ordinal- looking
for themes

Frequency,
Percentage

How many eye drops are lost
and do not make it into your
eye(s) per dose?
- No drops are lost per dose
- 1 to 2 drops are lost per dose
- 3 to 4 drops are lost per dose
- More than 5 drops are lost per
dose

Ordinal

Frequency,
Percentage

Instructions in larger font would
improve your ability to see and
read the instructions clearly.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage

Having your health care
professional demonstrate how to
properly use your eye drops
would improve your ability to
use them on your own.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage
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Table 3.1
Table of Specifications
An eye drop dispenser tool
would improve your ability to
properly use your eye drops.
1- Strongly Agree
2- Somewhat Agree
3- Indifferent
4- Somewhat
Disagree
5- Strongly Disagree

Ordinal

Frequency,
Percentage

Do you have a physical
limitation that makes using eye
drops difficult? Does this
limitation require additional
tools or devices to assist in using
eye drops?

Ordinal- looking
for themes

Frequency,
Percentage

Does the location of where you
instill eye drops (your
environment) impact your ability
to use them?

Ordinal- looking
for themes

Frequency,
Percentage

* Indicates level of data for survey items or methods, not RQ’s

To evaluate narrative responses from the open-response questions on the survey
instrument this study used the ethnographic statistical procedure. According to Vinson
(2012, p.1) the ethnographic method is “a data-driven method for analyzing real world
observations provided by others.” The ethnographic statistical procedure was appropriate
for this study because this procedure is more reliable for qualitative evaluation
techniques. This procedure analyzes valid measures for population-defined constructs by
identifying common themes shared among the responses to these open-response
questions.

For this study, ethnographic procedure was used to make systematic

observations from the narratives provided from the participants. Trends or themes
observed in data collected are discussed in the following chapters.
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Chapter IV: Findings
Introduction
The purpose of this research was to assess and evaluate elderly patients’ attitudes
and behavior about educational and physical barriers and the impact on adherence to
ocular pharmaceuticals. In order to collect data a 19 question survey was developed and
administered in person at the Edina Senior Center and Burnsville Senior Center and
online via Zoomerang ™ regarding attitudes on educational and physical barriers and
their impact on ocular pharmaceutical adherence. The findings from the quantitative and
qualitative analysis for each research question are presented in this chapter.
Survey Responses
After IRB approval was obtained, data collection occurred over a time frame of
two weeks from February 25, 2015 to March 11, 2015. A total of 140 survey responses
were collected for this research study. Sixteen of these surveys were collected from inperson tabling events; six from the Edina Senior Center during a Bridge game night and
10 from Burnsville Senior Center during a scheduled social painting event. The online
survey was open and responses were collected for 14 days from February 25, 2015 to
March 11, 2015. One hundred and twenty-four responses were collected electronically.
Eligible Survey Responses
Thirty-four survey responses collected were considered eligible for the scope of
this research study. The respondents included in this analysis met the inclusion criteria of
being 65 years of age or older, undergoing the treatment of an eye condition, and the use
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of eye drops as part of their ocular pharmaceutical therapy. A flow chart for determining
participant eligibility for this research study is presented in this chapter. (See Figure 4.1).
Because of the design of this research study both quantitative and qualitative statistical
analyses were used to answer the research questions. By completing the survey
instrument and/or by signing the consent form, participants gave consent. Responses
from the 34 eligible participants who met the inclusion criteria of being 65 years of age or
older, treating an ocular condition, and using eye drops as part of their ocular therapy
were coded and entered into a SPSS database for analysis.
Ineligible Survey Responses
One hundred and six survey responses were considered ineligible for the scope of
this research study. Specifically, nine survey responses were excluded from analysis
based upon age criteria because five respondents were less than 65 years of age, three
respondents did not provide their age in years, and one respondent did not provide their
age in an interpretable format. Additionally, seventy survey responses were excluded
from analysis because the respondents indicated they were not being treated for an eye
condition. Specifically, these respondents indicated ‘no’, ‘none, or ‘NA’ to this question
and eight respondents did not provide a response or left this question blank. Of the
respondents with an eye condition, twenty-seven respondents indicating their treatment
did not include the use of eye drops as part of their therapy.
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Respondents Demographics
The demographic information obtained from this research study included the age
and gender of the respondents. The median age of the eligible respondents is 69 years of
age. The range of ages of the respondents is 65 years to 99 years. Demographic data
revealed that 38.2% (n= 13) were male, 58.8% (n=20) were female, and 2.9% (n=1) did
not indicate a gender.
In order to identify selected elderly patients using ocular pharmaceuticals as part
of their therapy, participants were asked to describe their ocular conditions. All 34
participants responded to this question. This included identification with a singular ocular
condition or multiple ocular conditions being treated with ocular pharmaceuticals. 36.6%
(n = 15) identified as having dry eye, 19.5% (n = 8) identified as having Glaucoma,
12.2% (n = 5) identified as having cataracts, 4.9% (n = 2) identified as having Macular
Degeneration, 4.9% (n = 2) identified as having Allergies, 4.9% (n = 2) identified as
having near-sightedness (myopia), 2.4% (= 1) identified as having sensitivity to light,
2.4% (n= 1) identified as having stroke, 2.4% (n = 1) identified as having Strabismus,
2.4% (n = 1) identified as having Shingles, 2.4% (n = 1) identified as having Sjogren’s
Syndrome, and 2.4% (n = 1) identified as having to wear glasses. (See table 4.1.)
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Table 4.1
Ocular Conditions Reported by Elderly Patients Currently Being Treated with Ocular
Pharmaceuticals
Ocular
Male
Female
Gender Not Frequency
%
Condition
Specified
Dry eyes
1
13
1
15
36.6
Glaucoma

5

3

0

8

19.5

Cataracts

4

1

0

5

12.2

Macular
Degeneration
Allergies

0

2

0

2

4.9

1

1

0

2

4.9

Good

2

0

0

2

4.9

Nearsightedness
(Myopia)

0

2

0

2

4.9

Sensitivity to
light

0

1

0

1

2.4

Stroke

1

0

0

1

2.4

Strabismus

1

0

0

1

2.4

Shingles

1

0

0

1

2.4

Sjogren’s
Syndrome

0

1

0

1

2.4

Total
Responses

16

24

1

41

100
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Research Question 1: For elderly patients, how can the educational barrier of
a lack of understanding how to properly instill ocular pharmaceuticals be addressed
and mitigated?
In order to understand how the educational barrier of a lack of understanding how
to properly instill ocular pharmaceuticals can be addressed and mitigated; participants
were asked to designate the frequency of visits to an optometrist or ophthalmologist. All
34 participants provided a response; 2.9% (n = 1) participants reported they never made a
visit to their optometrist or ophthalmologist, 44.1% (n = 15) reported they visit their
optometrist or ophthalmologist 1 time each year, 38.2% (n = 13) reported they visit their
optometrist or ophthalmologist 2 to 3 times each year, and 14.7% (n = 5) reported they
visit their optometrist or ophthalmologist more than 4 times each year. (See table 4.2).
Table 4.2
Frequency of Visits to an Optometrist or Ophthalmologist as Reported by Elderly
Patients Currently Being Treated with Ocular Pharmaceuticals
Responses
Male
Female
Gender Not Frequency
%
Specified
Never
1
0
0
1
2.9
1 time each
year
2 to 3 times
each year

4

11

0

15

44.1

6

7

0

13

38.2

More than 4
times each
year

2

2

1

5

14.7

Total
Responses

13

20

1

34

100
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Participants were asked to indicate the healthcare professional who provided their
instructions for ocular pharmaceuticals. All 34 participants provided a response; 73.5% (n
= 25) reported Optometrists or Ophthalmologist, 5.9% (n = 2) reported General or
Primary Physician, 2.9% (n = 1) reported Nurse, 2.9% (n = 1) reported Pharmacist,
11.8% (n = 4) reported No one, and 2.9% (n = 1) reported Self. (See table 4.3).

Table 4.3
Health Care Professional Who Provide Ocular Pharmaceutical Instructions as Reported
by Elderly Patients Currently Being Treated with Ocular Pharmaceuticals
Responses
Male
Female
Gender Not Frequency
%
Specified
Optometrist or
10
14
1
24
73.5
Ophthalmologists
General or
Primary
Physician

1

1

0

2

5.9

Nurse

0

1

0

1

2.9

Pharmacist

0

1

0

1

2.9

No One

1

3

0

4

11.8

Self

1

0

0

1

2.9

Total Responses

13

20

1

34

100
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Participants were asked to denote the number of ocular pharmaceuticals they are
using as part of ocular treatment. All 34 participants provided a response; 70.6% (n = 24)
reported using one ocular pharmaceutical, 23.5% (n = 8) reported using two ocular
pharmaceuticals, and 5.9% (n = 2) reported using three or more ocular pharmaceuticals.
(See table 4.4).

Table 4.4
Number of Ocular Pharmaceuticals Used in Ocular Treatment as Reported by Elderly
Patients Currently Being Treated with Ocular Pharmaceuticals
Responses
Male
Female
Gender Not Frequency
%
Specified
One
9
15
0
24
70.6
Two

3

5

0

8

23.5

Three or more

1

0

1

2

5.9

Total
Responses

13

20

1

34

100
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Participants were asked to denote the duration of their ocular therapy. All 34
participants provided a response; 0.0% (n = 0) reported therapy lasting less than 1 week,
8.8% (n = 3) reported 1 to 2 weeks, and 91.2% (n = 31) reported three or more weeks.
(See table 4.5).

Table 4.5
Duration of Ocular Therapy as Reported by Elderly Patients Currently Being Treated
with Ocular Pharmaceuticals
Responses
Male
Female
Gender Not Frequency
%
Specified
Less than 1
0
0
0
0
0.0
week
1 to 2 weeks

2

1

0

3

8.8

3 or more
weeks
Total
Responses

11

19

1

31

91.2

13

20

1

34

100
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Participants were asked to indicate the number of eye drops lost and did not make
it into the eye(s) per dose when used in ocular treatment. All 34 participants provided a
response; 47.1% (n = 16) reported no drops, 47.1% (n = 16) reported 1 to 2 drops, 2.9 %
(n = 1) reported 3 to 4 drops, and 2.9 % (n = 1) reported more than 5 drops. (See table
4.6).

Table 4.6
Number of Eye Drops Lost and Did Not Make It in to the Eye (s) Per Dose When Used in
Ocular Treatment as Reported by Elderly Patients Currently Being Treated with Ocular
Pharmaceuticals
Responses
Male
Female
Gender Not Frequency
%
Specified
No drops
8
8
0
16
47.1
1 to 2 drops

5

11

0

16

47.1

3 to 4 drops

0

0

1

1

2.9

More than 5
drops

0

1

0

1

2.9

Total
Responses

13

20

1

34

100
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Participants were asked to indicate their agreement with the statement,
“Instructions on the eye drop box are clear and easy to understand.” All 34 participants
responded to this question; 61.8% (n = 21) reported strongly agree, 23.5% (n = 8)
reported somewhat agree, 8.8% (n = 3) reported indifferent, 2.9% (n = 1) reported
somewhat disagree, and 2.9% (n = 1) reported strongly disagree. (See table 4.7).

Table 4.7
Instructions on the eye drop box are clear and easy to understand
Responses
Male
Female
Gender Not Frequency
Specified
Strongly Agree 7
13
1
21

%
61.8

Somewhat
Agree

3

5

0

8

23.5

Indifferent

1

2

0

3

8.8

Somewhat
Disagree

1

0

0

1

2.9

Strongly
Disagree

1

0

0

1

2.9

Total
Responses

13

20

1

34

100
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Participants were asked to indicate their agreement with the statement, “Word
choice to explain instructions is clear to understand how to use your eye drops.” All 34
participants responded to this question; 67.6% (n = 23) reported strongly agree, 17.6% (n
= 6) reported somewhat agree, 11.7% (n = 4) reported indifferent, 2.9% (n = 1) reported
somewhat disagree, and 0.0% (n = 0) reported strongly disagree. (See table 4.8).

Table 4.8
Word choice to explain instructions is clear to understand how to use your eye drops
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 7
15
1
23
67.6
Somewhat
Agree

3

3

0

6

17.6

Indifferent

2

2

0

4

11.7

Somewhat
Disagree

1

0

0

1

2.9

Strongly
Disagree

0

0

0

0

0.0

Total
Responses

13

20

1

34

100
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Participants were asked to indicate their agreement with the statement, “The use
of pictures to illustrate would improve your understanding of the eye drop instructions.”
All 34 participants responded to this question; 29.4% (n = 10) reported strongly agree,
17.6% (n = 6) reported somewhat agree, 32.3% (n = 11) reported indifferent, 8.8% (n =
3) reported somewhat disagree, and 11.8% (n = 4) reported strongly disagree. (See table
4.9).

Table 4.9
The Use of Pictures to Illustrate Would Improve your Understanding of the Eye Drop
Instructions
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 2
8
0
10
29.4
Somewhat
Agree

2

4

0

6

17.6

Indifferent

6

4

1

11

32.3

Somewhat
Disagree

1

2

0

3

8.8

Strongly
Disagree

2

2

0

4

11.8

Total
Responses

13

20

1

34

100
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Participants were asked to indicate their agreement with the statement, “The use
of a video demonstration would improve your understanding of the eye drop
instructions.” All 34 participants responded to this question; 17.6% (n = 6) reported
strongly agree, 11.8% (n = 4) reported somewhat agree, 38.2% (n = 13) reported
indifferent, 8.8% (n = 3) reported somewhat disagree, and 23.5% (n = 8) reported
strongly disagree. (See table 4.10).

Table 4.10
The Use of a Video Demonstration Would Improve your Understanding of the Eye Drop
Instructions
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 1
5
0
6
17.6
Somewhat
Agree

2

2

0

4

11.8

Indifferent

6

6

1

13

38.2

Somewhat
Disagree

1

2

0

3

8.8

Strongly
Disagree

3

2

0

8

23.5

Total
Responses

13

20

1

34

100
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Open-Response Questions Addressing Educational Barriers
Thirteen respondents did not elaborate or provide further detail on the openresponse survey questions. Detailed experiences provided by other participants hit keenly
on key words and phrases. Ethnographic analysis of their experiences identified two main
categories of eye drop users; experienced and inexperienced. Experienced users
suggested instruction provided with or without provider interactions were clear and easy
to understand. Inexperienced users highlighted instructional needs for first-time eye drop
users. Notable suggestions from the participants also included recommendations for
product and provider improvement. It was recommended that ocular pharmaceutical
could have dosage indicators on the products themselves and if instructional time with
the provider could be increased.
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Research Question 2: For elderly patients, how can physical barriers be
addressed to improve the ability to properly self-administer eye drops as
prescribed?
In order to understand how physical barriers could be addressed to improve the
ability to properly self-administer eye drops as prescribed; participants were asked to
indicate their agreement with the statement, “Instructions in larger font would improve
your ability to see and read the instructions clearly.” All 34 participants responded to this
question; 58.8% (n = 20) reported strongly agree, 29.4% (n = 10) reported somewhat
agree, 5.9% (n = 2) reported indifferent, 0.0% (n = 0) reported somewhat disagree, and
5.9% (n = 2) reported strongly disagree. (See table 4.11).

Table 4.11
Instructions in Larger Font Would Improve your Ability to See and Read the Instructions
Clearly
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 7
12
1
20
58.8
Somewhat
Agree

5

5

0

10

29.4

Indifferent

1

1

0

2

5.9

Somewhat
Disagree

0

0

0

0

0.0

Strongly
Disagree

0

2

0

2

5.9

Total
Responses

13

20

1

34

100
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Participants were asked to indicate their agreement with the statement; “Having
your health care professional demonstrate how to properly use your eye drops would
improve your ability to use eye drops on your own.” All 34 participants responded to this
question; 38.2% (n = 13) reported strongly agree, 20.6% (n = 7) reported somewhat
agree, 26.5% (n = 9) reported indifferent, 8.8% (n = 3) reported somewhat disagree, and
5.9% (n = 2) reported strongly disagree. (See table 4.12).

Table 4.12
Having your Health Care Professional Demonstrate how to Properly Use your Eye
Drops Would Improve your Ability to Use Eye Drops on your Own
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 5
7
1
13
38.2
Somewhat
Agree

2

5

0

7

20.6

Indifferent

3

6

0

9

26.5

Somewhat
Disagree

2

1

0

3

8.8

Strongly
Disagree

1

1

0

2

5.9

Total
Responses

13

20

1

34

100
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Participants were asked to designate their agreement with the statement; “An eye
drop dispenser tool would improve your ability to properly use your eye drops.” All 34
participants responded to this question; 20.6% (n = 7) reported strongly agree, 29.4%
(n = 10) reported somewhat agree, 32.4% (n = 11) reported indifferent, 11.8% (n = 4)
reported somewhat disagree, and 5.9% (n = 2) reported strongly disagree. (See table
4.13).

Table 4.13
An Eye Drop Dispenser Tool Would Improve your Ability to Properly Use your Eye
Drops
Responses
Male
Female
Gender Not Frequency
%
Specified
Strongly Agree 2
5
0
7
20.6
Somewhat
Agree

4

6

0

10

29.4

Indifferent

4

6

1

11

32.4

Somewhat
Disagree

2

2

0

4

11.8

Strongly
Disagree

1

1

0

2

5.9

Total
Responses

13

20

1

34

100
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Open-Response Fields Addressing Physical Barriers
Twenty-nine respondents did not elaborate or provide further detail on the openresponse survey questions related to experiences with physical barriers to ocular
pharmaceutical use. Responses provided from five participants were brief and candid
explanations of their physical barriers to ocular pharmaceutical adherence. One
participant indicated the need for glasses in order to read the instructions. Another
participant indicated he had only one arm and required a stint for their eye-lid. Two
participants noted mechanical limitations of carpal tunnel and hand tremors. One
participant indicated their Alzheimer’s disease as a mental limitation. For this research
study each of the experiences provided on physical barriers to ocular pharmaceuticals
were unique. These physical barrier experiences demonstrate a considerably wide range
of what patients consider a physical barrier or limitation to ocular instillation.
Open-Response Question Addressing Environmental Barriers
Twenty-eight respondents did not elaborate or provide further detail on the openresponse survey questions related to experiences with environmental barriers to ocular
pharmaceutical use. Two participants indicated that location does impact their ability to
use ocular pharmaceuticals, but did not elaborate further. Two participants described their
experiences with environmental barriers. One participant described better accuracy
instilling eye drops in darkness rather than in the light. The second participant who
provided an experience described an important reminder technique based on the time of
day for which they administer the ocular pharmaceutical. That technique, is to keep the
ocular pharmaceuticals in a convenient and easy to remember location.
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Summary
Quantitative and qualitative data analysis demonstrated trends regarding elderly
patient adherence to ocular pharmaceuticals and the impact of educational and physical
barriers, supported the purpose of this research study. The findings identified that there
were elderly patients who believed they were adhering to their ocular therapy. A majority
of the participants in this research see a health care professional regularly to receive
instructions on how to instill ocular pharmaceuticals. This research uncovered that most
elderly patients using ocular pharmaceuticals indicated agreement that there are benefits
to addressing areas of educational and physical barriers to ocular pharmaceutical
adherence.
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Chapter V: Summary, Discussion, and Recommendations
Introduction
The purpose of this study was to assess and evaluate elderly patients’ attitudes
and behaviors regarding educational and physical barriers and their impact on adherence
to ocular pharmaceutical therapy. This research study strived to investigate how these
two types of barriers contributed to low adherence rates for elderly patients undergoing
ocular pharmaceutical therapy. The following research questions were examined in this
research study:
1. For elderly patients, how can the educational barrier of a lack of understanding of
how to properly instill ocular pharmaceuticals be addressed and mitigated?
2.

For elderly patients, how can physical barriers be addressed to improve the
ability to properly self-administer eye drops as prescribed?

Summary
This research study included thirty-four respondents who were ages 65 years or
older, currently undergoing ocular therapy, and being treated with a specific ocular
pharmaceuticals- eye drops. The timeframe in which this study was conducted was
during the fall 2014 through the spring 2015 semesters. Respondents by gender were
38.2% (n= 13) male, 58.8% (n=20) were female, and 2.9% (n=1) who did not indicate a
gender. The mean age of the eligible respondents was 87.65 years of age and range of
ages of the respondents was 65 years to 99 years. Data were collected for this research
study using a survey instrument. A printed version was distributed in-person at the Edina
Senior Center and the Burnsville Center and an online version distributed by Zoomerang
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™ survey tool. The survey questions were designed and tested in a pilot study to gather
data about elderly patient’s attitudes, behaviors, and experiences regarding educational
and physical barriers and their impact upon ocular pharmaceutical adherence.
Discussion
The population size of eligible respondents for this research study was reasonable
provided the noted limitations. An assumption made by this researcher was that a higher
percentage of ocular pharmaceutical users would be among the elderly population. Of the
135 respondents who met the age inclusion criteria (of 65 years of age and older) only 61
noted they were treating an eye condition, and of those 61 only 34 used ocular
pharmaceuticals as part of their treatment of an eye condition or eye conditions.
Therefore the sample population of respondents who are actually treating and ocular
condition with eye drops was 27.2%.
A survey question asked participants to indicate the number of eye drops lost and
did not make it into the eye(s) per dose when used in ocular treatment. Forty-seven and
one-tenth percent (n = 16) of respondents reported no drops were lost and 47.1% (n = 16)
reported 1 to 2 drops were lost, and just 2.9 % (n = 1) reported loosing more than 5 drops.
However, several studies reviewed that recorded greater loss than that reported by
patients. Hennessy, Katz, Covert, Protzko, and Robin (2010) observed glaucoma patients
instilling their ocular pharmaceuticals and found only 71% percent of subjects were able
to get a single drop onto the eye following instructions. This indicates that self-reporting
of loss by a patient may be less than the amount lost in practice.
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Educational barriers
The responses collected from respondents treating an ocular condition with ocular
pharmaceuticals indicated strong agreement that reducing educational barriers was
beneficial. Participants described their desire to address educational barriers with eye care
providers and with ocular pharmaceutical products. One respondent stated literacy
concerns and the use of illustrations as helpful. In regards to the statement, “The use of
pictures to illustrate would improve your understanding of the eye drop instructions.”
29.4% (n = 10) of study participants reported strongly agree and 17.6% (n = 6) reported
somewhat agree suggesting that pictographic instructions would improve understating of
instillation.
Findings from this study about the educational experiences of the respondents
exposed a desire for elderly patient education for first time ocular pharmaceutical users
and increasing time with providers for education on instillation. Shea (2006, p.7) also
promoted this suggestion for increased health education, as “during the medication
education phase of the appointment can significantly improve adherence.” This study
supports the desire for increased health education opportunities for ocular
pharmaceuticals to improve elderly patient adherence to this class of medications.
Physical barriers
The responses collected from respondents treating an ocular condition with ocular
pharmaceuticals expressed a strong agreement with improving upon physical barriers as a
beneficial idea. There was strong support for larger font provisions, 58.8% (n = 20)
reported strongly agree and 29.4% (n = 10) reported somewhat agree with the survey
question statement, “Instructions in larger font would improve your ability to see and
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read the instructions clearly.” Reducing this burdening factor has the potential to impact
medication adherence. Shrank, Avorn, Rolon, and Shekelle, (2007) support label
formatting such as the use of larger fonts, lists, headers, and white space, using simple
language and logical organization to improve readability and comprehension. Findings
from this study also demonstrate the research study participants’ interest in addressing
physical barriers to instillation with dispenser aides. Specifically, 20.6% (n = 7)
participants reported strongly agree and 29.4% (n = 10) reported somewhat agree with
the statement, “An eye drop dispenser tool would improve your ability to properly use
your eye drops.” The desire to improve instillation shows that elderly patients undergoing
ocular pharmaceutical therapy are responsive to using an ocular pharmaceutical
dispensing tool. This level of agreement by the research study population would suggest
the need to research further and present this as a quality of healthcare need to eye care
providers, other healthcare professionals dispensing ocular pharmaceuticals, and the
manufacturing producers of ocular pharmaceuticals.
This study also found through participant experiences that a variety of physical
conditions that are not directly related to ocular conditions were self-reported as physical
barriers. Respondents in this research study experienced hand tremors, Alzheimer’s
disease, and carpal tunnel as physical barriers. One respondent indicated he is one-handed
and required the use of a stump to hold eyelid. Each of these experiences indicates that
ocular therapy is a unique treatment and providers and patients should work together to
support successful treatments that overcome physical barriers. From the experiences
evaluated in this study, adjustments could range from needing glasses to read instructions
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to the use of a dispenser aid or stump. However, treatment options should be discussed
and evaluated to suit the needs of each patients agreed upon ocular therapy plan.
Limitation and Delimitations
A limiting factor to in-person data collection was the timeframe. The Edina
Senior Center and the Burnsville Senior Center are open primarily during daytime hours.
During in-person table events collecting survey responses during social hour activities
was more successful than planned structured activities at both senior centers. Table
events during the social activities resulted in a higher volume of participants willing to
participate in the research study. Those arriving at the senior center for an activity were
able to leisurely talk to the researcher about the study and take the survey. During
structured activity times, visitors of the senior centers did not want to stop at the table and
declined interested in talking to the researcher. Online survey collection had a notably
higher volume of respondents. Several factors may have contributed to the success of this
survey collections method such as, elderly users of computers and Internet may be more
technologically savvy than their peers. Additionally, the online survey participants had
the liberty of taking the survey when there was a convenient time during the two-week
timeframe in which the survey link was active.
Another limiting factor was the sample population size of eligible participants.
Establishing a partnership with an eye care clinic may result in a higher concentration of
persons who are treated with ocular pharmaceuticals. Another way to recruit more
eligible participants is to expand the inclusion criteria to include responses of non-ocular
pharmaceutical users who are treating an eye condition to gather an alternative
perspective on instillation. Increasing both the time available for data collection and the
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eligible number of participants would provide more viable data to investigate ocular
pharmaceutical adherence and the impact of educational and physical barriers.
Recommendations for Health Education Profession
Findings from this study provided data regarding attitudes, behaviors, and
experience about elderly patient adherence to ocular pharmaceuticals and the impact of
educational and physical barriers. These findings suggest there is a gap in the health
education profession of the need for health educators and professionals to provide
educational opportunities to elderly ocular therapy patients. Findings of this study
demonstrate elderly participants sampled 38.2% (n = 13) reported strongly agreeing with
the statement, “Having your health care professional demonstrate how to properly use
your eye drops would improve your ability to use eye drops on your own.” In order to
increase the knowledge base of elderly patients, it is essential to integrate this information
into the patient education conversations at ocular therapy appointments.
Revisiting the Health Belief Model used to support this study, this model will
continue to aid health educators in identifying the perceived barriers to ocular
pharmaceutical adherence and the equally important benefits of instilling ocular
pharmaceuticals appropriately. As a supportive model, the Health Belief Model has
proven suitable in this study and applied to developing data collection methods and
strategies to improve ocular pharmaceutical education conversations between elderly
patients and providers.
Recommendations for Future Research
Results of this research study indicate a need to gather data from a broader sample
of elderly patients using ocular pharmaceuticals. This would enrich the knowledge base
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available on educational and environmental barriers to ocular pharmaceutical adherence
and increase the validity of findings from the attitudes, behaviors, and experiences.
A recommendation this study makes is to increase the amount of detailed
experiences elderly patients will share regarding their attitudes and behavior towards
educational and physical barriers to using ocular pharmaceuticals. This could be an
adjustment to data collection instruments. Re-formatting and repurposing of the open
response questions in the form of a focus group or conducting interviews may elicit more
detailed and descriptive responses in order to achieve the objective of gaining more
knowledge than what is available. Using additional health education research techniques
to investigate further would allow for deeper insight into educational and physical
barriers to ocular pharmaceutical adherence.
Additionally, the need to investigate possible interventions is evident from this
study of elderly patient adherence to ocular pharmaceuticals and the impact of
educational and physical barriers. Expanding on each of the targeted survey questions to
gain more detail regarding the educational and physical barriers. Follow up needs
assessments built from the questions focused on educational barriers could assess the
impact of interventions focusing on video and illustrative instructions on elderly patient
ocular pharmaceutical adherence. Follow up needs assessments built from the questions
focused on physical barriers could assess the impact of interventions focusing on larger
font formatting or the use of dispenser aides on elderly patient ocular pharmaceutical
adherence.
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the solution,
and the
manner the
patient
dispenses
drops

Six
electronic
databases
were
searched
using the
following
categories
of search
terms:
health care
professiona
ls,
patients/co
nsumers,
medicinetaking/pres
cribing and
communica
tion.
NA

Studi
es
publi
shed
betw
een
1991
and
2000
were
inclu
ded

30

NA

NA

NA

NA

NA

In this
review, the
technical,
pharmaceuti
cal, and
therapeutic
aspects of
eye drop
formation
and delivery
are
presented.

95
31

NA

NA

86 Studies.

Selfreport
versus
non selfreport
studies.

A literature
search was
conducted to
identify
published
reports in
which selfreport and
non-selfreport
measures of
adherence
were used
within the
same study.
Review of
interventions
designed to
address nonadherence to
therapeutic
regimens.

The
concordanc
e of
measures
within each
study was
categorized
as high,
moderate,
or low.

2004

32

NA

NA

NA

NA

Literature
review.
Various
sources.
Queen's
University
in Belfast,
Northern
Ireland.

NA

No
consensus in
the literature
that age is a
predictor of
poor
adherence.

33

NA

NA

NA

NA

NA

NA

Adherence,
formerly
referred to as
compliance,
is a patientcentered
term. It
suggests that
patients
carry out and
maintain
certain
behaviors,
such as
taking
medications,
after making
an informed
choice in a
supportive
environment.

NA

NA

NA

National
initiative
by the Case
Manageme
nt Society
of America
to train
case
managers
in
psychosoci
al
behavioral
change and
apply
adherence
interventio
ns through
a set of
evidencebased
guidelines
Review of
conducted
studies.

34

NA

NA

NA

Good review
of tools
available.

35

NA

NA

NA

NA

NA

NA

NA

Website
designed to
help elderly
outpatients.

36

NA

NA

NA

NA

NA

NA

NA

Editorial
article.
Recommend
ations to
enhance
adherence to
medications.

96
37

Older
adults'
medicat
ion
adheren
ce.

Personal and
cultural
beliefs.

14 studies.

Adults
who are
often
prescribed
medicatio
ns for agerelated
chronic
disorders.

Systematic
literatures
searches
using ten
databases.
A review
of research
studies
published
in journals
across
different
disciplines.
NA

NA

NA

The majority
of the studies
in the review
evaluated
older adults'
medication
adherence by
self-report and
used crosssectional
designs and
convenience
samples.
NA

38

NA

NA

NA

39

NA

NA

NA

NA

NA

NA

NA

40

Subject
respons
es.

Medication
adherence
questions.

NA

National
stratified
random
sample of
communit
ydwelling
Medicare
members
65 years
and older.

Nationwide
crosssectional
survey.

Factor
analysis of
survey
responses.

20052006

41

Informationa
l, behavioral,
and/or
social, or
combined
interventions
.

37 eligible
trials.

Patients
with
chronic
medical
conditions
.

Janua
ry
1967
to
Septe
mber
2004

NA

NA

Generaliz
ed eye
drop use

Study
characteristics
and results for
adherence and
clinical
outcomes
were
extracted.
NA

Published
Randomize
d
controlled
trials

42

Effect
size of
interven
tions
and
clinical
adheren
ce.
NA

National
Institute of
Health

NA

43

NA

NA

Not
specified.

Qualitative
methodology
investigated
aspects of
adherence.

Recruited
patients
attended
focus
groups or
had a
homebased
semistructured
interview.

2006

44

NA

NA

NA

Participan
ts had
moderate/
severe
glaucoma
diagnosed
for >1
year and
prescribed
2 or more
medicatio
ns.
NA

NA

NA

NA

NA

Illustrative
instructions

Theoretical
support and
definitions

97
45

Patient
success
rate of
ability
to
instill
eye
drop as
instruct
ed.

Eye drop
container
type. Control
group:
applied
drops from
single-use
eye drop
containers.
Group B:
traditional
eye drop
bottle.

44 patients.

Patients
aged ≥80
years who
had no
physical
or mental
conditions
hindering
selfapplicatio
n of eye
drops

Two
investigators,
who
documented
practical
problems
during the
procedure in a
checklist,
observed
patients.

Randomize
d
controlled
study

Not
speci
fied.

46

NA

NA

NA

Measuring
adherence
in each
study

Searches of
The
Cochrane
Library,
MEDLINE
, CINAHL,
EMBASE,
Internation
al
Pharmaceut
ical
Abstracts
(IPA),
PsycINFO
(all via
OVID) and
Sociologica
l Abstracts
(via CSA) i
with no
language
restriction.

Jan07

47

NA

NA

63 studies.

Older
adults >
60 years
of age
who are
selfmedicatin
g.

Articles were
selected if
they reported
an
uncompounde
d RCT of an
intervention to
improve
adherence
with
prescribed
medications,
measuring
both
medication
adherence and
treatment
outcome, with
at least 80%
follow-up of
each group
studied and,
for long-term
treatments, at
least six
months
follow-up for
studies with
positive initial
findings.
Literature
review.

Computeriz
ed database
searches,
journal
hand
searches,
and
ancestry
searches.

19772005

Frequency of
problems
during
opening and
selfapplication
of single-use
eye drop
containers in
the study
group
showed an
inverse
correlation
to visual
acuity in the
better eye
and previous
experience
with this
kind of eye
drop
container.

Low
medication
adherence
rates among
some elderly
contributes
to
inadequate
pharmacolog

98
ical
management
of illnesses
48

NA

NA

NA

NA

Review of
evidence
based
interventions.

Review of
conducted
studies.

2005

49

Patient
adheren
ce
medicat
ion
rates.

66 patients.

Patients
with
glaucoma
being
treated
with a
prostaglan
din analog
in one or
both eyes.

Randomized
controlled
study.

Interventio
n.

Nove
mber
2006
and
June
2007

50

NA

Watched an
educational
video,
reviewed
current
barriers to
drop-taking
and possible
solutions
with a study
coordinator,
received
regular
phone call
reminders,
and had
audible and
visible
reminders.
NA

NA

American
adults.

Articles were
grouped and
summarized
into three
broad
categories
(nonadherenc
e, health
literacy, and
communicatin
g health
information to
patients), with
an emphasis
on the use of
written patient
information in
health care
and pharmacy
practice in
particular.

Searches of
Medline,
PubMed,
and
Internation
al
Pharmaceut
ical
Abstracts
databases
were
conducted
using one
or more of
the
following
terms
adherence/
nonadheren
ce,
compliance
/noncompli
ance,
printed/writ
ten
information
, literacy,
patient
education,
communica
tion, and
health
literacy.

2008

This is a
handbook.

99
51

Patient
adheren
ce rates.

Participants
were divided
into a group
with High
Cognitive
Function
(HCF) or
Low
Cognitive
Function
(LCF) based
on their
scores on the
ADAS-Cog.
Educational
meetings
alone or
combined
with other
interventions
.

38 patients.

Patients
aged 65
years and
older.

This was a
crosssectional
study of the
ability of
independently
living healthy
elders to
follow a
medication
regimen.

Adherence
was
measured
using an
electronic
7-day
pillbox.

2009

52

Outcom
e of
confere
nces.

81 trials
involving
more than
11,000
health
professiona
ls.

Profession
als’
conferenc
e.

Randomized
controlled
trials of
educational
meetings that
reported an
objective
measure of
professional
practice or
healthcare
outcomes.

19992006

Educational
meetings
alone or
combined
with other
interventions
can improve
professional
practice and
healthcare
outcomes for
the patients.

Effectiv
eness of
interven
tions.

Tailored
interventions
.

26 studies.

Randomiz
ed
controlled
trials
(RCTs) of
interventi
ons.

Metaregression to
compare
interventions
tailored to
address
identified
barriers to
change with
either no
interventions
or an
intervention(s
) not tailored
to the barriers.

20072009

Interventions
tailored to
prospectivel
y identified
barriers are
more likely
to improve
professional
practice than
no
intervention
or
disseminatio
n of
guidelines.

54

NA

NA

NA

NA

NA

Searching
the
Cochrane
Effective
Practice
and
Organizatio
n of Care
Group
Trials
Register
and
pending
file.
Database
searches
without
language
restrictions,
from
inception
until
August
2007:
MEDLINE
,
EMBASE,
CINAHL,
BNI and
HMIC.
Various
references

53

NA

55

NA

NA

NA

NA

NA

NA

NA

Good
definitions
and tools for
educators
Recommend
ation to
share
medication
management
responsibiliti
es following
the patientcentered
medical
home model
of care

100
56

Eye
drop
adminis
tration.

Subjects
with
glaucoma or
retinal
diseases.

409
subjects
(205
glaucoma,
204 retina).

Glaucoma
or retinal
diseases
with
visual
acuity of
20/60 or
worse in 1
eye,
significant
field loss,
or both.

Study was
divided by
diagnosis.

Recorded
clinical
examinatio
n.

20102011

Both groups
wasted
drops,
contaminate
d bottles,
and had
inaccurate
perception of
their
abilities.

57

NA

NA

NA

Elderly
patients
(i.e., ≥65
years of
age) in the
United
States.

The
PubMed
and
PsychINFO
databases
were
searched
for articles
published
in English
between
January
1998 and
January
2010

19982010

Described
“predictors,”
“facilitators,
” or
“determinant
s” of
medication
adherence.

58

NA

NA

NA

NA

Nonsystemati
c reviews
were
excluded, as
were studies
that focused
specifically on
people who
were
homeless or
substance
abusers, or
patients with
psychotic
disorders,
tuberculosis,
or HIV
infection,
because of the
unique
circumstances
that surround
medication
adherence for
each of these
populations.
NA

NA

NA

59

NA

NA

NA

NA

NA

Review of
other
studies.

NA

Tips for the
pharmacist
include
demonstratin
g proper
instillation
technique
each time a
patient
presents a
new
prescription,
and observe
the patient
applying
drops.
Pharmacists
should also
remind
patients to
include eye

101
drops on
their
medication
lists, and
insist that
they need
them if they
are
hospitalized
60

Safe
medicat
ion use.

Illumination,
interruptions
and
distractions,
sound and
noise,
physical
design and
organization,
and
medication
safety zones.

NA

NA

The reports
described in
this column
were received
through the
ISMP
Medication
Errors
Reporting
Program
(MERP).
Errors, close
calls, or
hazardous
conditions
may be
reported on
the ISMP
Web site
(www.ismp.or
g) or
communicate
d directly to
ISMP by
calling 1-800FAIL-SAFE
or via e-mail
at
ismpinfo@is
mp.org.

61

The
ability
to
assess
concord
ance.

Patients who
were
administered
the
MedAdhIRST questions
and those
given the
MAQ
questions.

Not
specified.

Communit
ydwelling
elderly
population
.

A prospective,
observational
pilot study
comparing the
reliability and
validity of the
MedAdhIRST compared
against the
Medication
Adherence
Questionnaire
(MAQ).

The reports
described
in this
column
were
received
through the
ISMP
Medication
Errors
Reporting
Program
(MERP).
Errors,
close calls,
or
hazardous
conditions
may be
reported on
the ISMP
Web site
(www.ismp
.org) or
communica
ted directly
to ISMP by
calling 1800-FAILSAFE or
via e-mail
at
ismpinfo@
ismp.org.
Questionna
ire.
Explorator
y factor
analysis.

Not
speci
fied

Standards
are provided
in five key
areas—
illumination,
interruptions
and
distractions,
sound and
noise,
physical
design and
organization,
and
medication
safety zones.

2012

Accepted in
2014.

102
62

Patient
adheren
ce to
medicat
ion.

Living with
drugs, taking
medication,
belief about
drugs and
relationship
with health
professionals
.

NA

People
aged 65 or
more and
with
chronic
illness.

Data was
collected by
two focus
groups. The
content of
discussion
was analyzed
from verbatim
transcript and
identifying
categories and
sub-categories
emerged,
leading to the
construction
of a diagram
analysis.

Focus
groups.

20112012

63

NA

NA

NA

NA

NA

NA

NA

64

NA

NA

NA

NA

NA

Various
references.

NA

65

NA

NA

NA

NA

Annual report

Various
references

NA

66

Patient
adheren
ce
medicat
ion
rates.

Patients
receiving
patient
centered
health
promotion
approach.

NA

27 new
and
establishe
d patients
receiving
glaucoma
treatment.

Interviews.

The
interviews
were
transcribed
and then
analyzed
thematicall
y.

2012

67

NA

NA

NA

General
population
s of eye
drop users
and eye
care
providers.

Discussion
and
contribution
by health
professionals
working in
optometry,
ophthalmolog
y, medicine,
pharmacy,
and
development

Various
references.
Global
health
conference.

NA

The elderly
suggest that
the
relationship
with health
professionals
is essential
in
medication
management
and they
reported that
the
information
given by the
nurse during
consultation
is very
important.
CDC calls
out
educational
pointers.
Prepared by
the national
community
of
pharmacists
association.
Americans
had an
overall
compliance
score of a
C+.
Nine
categories of
health
education
needs were
identified.

Good topic
discussion
forum.

103
68

Particip
ant
respons
e.

Movement
from
periodic to
continuous
operation.

Unknownsome
cultures
provided
group
responses.

Māori,
Pacific
and Asian
population
s residing
in New
Zealand.

Disproportion
ate area
sampling and
a dual frame
design.

Use of core
questions
with
rotating
topic
modules to
improve
flexibility
in survey
content;
and
opportuniti
es for
ongoing
improveme
nts and
efficiencies
, including
linkage to
administrat
ive
datasets.
NA

Applicable
for survey
design. Not
specific to
any health
condition.

69

NA

NA

NA

NA

NA

70

NA

NA

NA

NA

NA

Various
references

NA

71

NA

NA

NA

NA

NA

Various
references

NA

72

NA

NA

NA

NA

NA

NA

NA

NA
Good for
definitions
and
utilization
rates.

University of
Arkansas
Medical
Sciences
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Appendix B: Approval Institutional Review Board

-1-

Generated on IRBNet
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Appendix C: In-Person Consent Form

Privacy and consent
• Purpose: The purpose of this study is to learn how patients who are using
eye drops to treat eye conditions perceive the educational and physical
barriers to effective use. You must currently be treated for an eye
condition to take part in this study.
• What we will ask: If you agree to be a participant in this study, we will
gather your responses to the survey questions. The survey questions will
take about 5 minutes to complete. The open response questions about
treatment of your eye condition, the educational or instructional barriers,
physical limitations, the environment, and how you feel this impacts your
ability to use eye drops will take about an additional 5 minutes to
complete.
• Risks: There is the risk that you could find a few of the questions about
your eye conditions to be sensitive. I do not anticipate any risks to you
participating in this study other than risks experienced in daily life.
• Benefits: There are no benefits to you.
• Compensation: There is no compensation for your participation.

106

• Confidentiality: The responses from this study will remain confidential.
Any publicly available report will omit any information that could make it
possible for you to be identified. Responses will be stored in a passwordprotected file accessible only by the researchers.
• Voluntary Participation: Participation is this study is voluntary. Any
questions that you do not want to answer may be skipped. You are free to
leave the study at any time without prejudice.
• Questions: This research project is being directed by Dr. Judith Luebke.
You can contact Dr. Luebke at 507-389-5938 or judith.luebke@mnsu.edu
about any concerns you have about this project. You also may contact the
Minnesota State University, Mankato Institutional Review Board
Administrator, Dr. Barry Ries, at 389-1242 or barry.ries@mnsu.edu with
any questions about research with human participants at Minnesota State
University, Mankato.
Statement of Consent: I have read the above information and have
received answers to any questions I asked. I consent to take part in the study.
Participants should initial each page.
Initials:____
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Submitting the completed survey will indicate your informed consent to
participate.
Printed Name__________________
Your Signature__________________

Date __________

The researchers will keep this consent form for a minimum of three years
beyond the end of the study. You may request a copy of this form for your
records.
Thank you, for your response and participation.
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Appendix D: Online Consent Form
ONLINE/ANONYMOUS SURVEY CONSENT
You are requested to participate in research supervised by Dr. Judith K. Luebke
on elderly patient adherence to ocular pharmaceuticals and impact of educational and
physical barriers. This survey should take about 10 minutes to complete. The goal of this
survey is to understand how patients who are using eye drops to treat eye conditions
perceive the educational and physical barriers to effective use, and you will be asked to
answer questions about that topic. If you have any questions about the research, please
contact Dr. Luebke at Judith.luebke@mnsu.edu.
Participation is voluntary. You have the option not to respond to any of the
questions. You may stop taking the survey at any time by closing your web browser.
Participation or nonparticipation will not impact your relationship with Minnesota State
University, Mankato. If you have questions about the treatment of human participants and
Minnesota State University, Mankato, contact the IRB Administrator, Dr. Barry Ries, at
507-389-2321 or barry.ries@mnsu.edu.
Responses will be anonymous. However, whenever one works with online
technology there is always the risk of compromising privacy, confidentiality, and/or
anonymity. If you would like more information about the specific privacy and anonymity
risks posed by online surveys, please contact the Minnesota State University, Mankato
Information and Technology Services Help Desk (507-389-6654) and ask to speak to the
Information Security Manager.
There is the risk that you could find a few of the questions about your eye
conditions to be sensitive. The risks of participating are no more than are experienced in
daily life.
There are no direct benefits for participating. Future studies on ocular
pharmaceutical could make use of this research.
Submitting the completed survey will indicate your informed consent to
participate and indicate your assurance that you are at least 18 years of age.
Please print a copy of this page for your future reference.
MSU IRBNet ID# 720717
Date of MSU IRB approval: February 24, 2015
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Appendix E: Survey instrument

Educational and Physical Barriers to Eye Drop Use
This survey asks questions about perceptions of educational and physical
barriers to learn about using eye drops to treat eye conditions effectively.
General Questions
1. What is your age in years? ____
2. What is your gender? M, F, Prefer not to answer
3. What is your eye condition(s)? _____
If you are not treating an eye condition(s), please indicate ‘none’ and
do not answer the following questions.
4. Do you use eye drops to treat your eye condition? ______
If you are not using eye drops please indicate ‘no’ and do not answer
the following questions.

Treatment
1. How frequently do you see your or eye care provider?
- Never
- 1time each year
- 2 times each year
- 3 times each year
- 4 times or more each year
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2. Who provides you with instructions on how to use your eye drops?
- Optometrist or Ophthalmologist
- General or Primary Physician
- Physicians’ assistant
- Nurse
- Pharmacist
- Other: Please, describe _______________
- No one
3. How many eye drop medications do you use to treat you eye condition?
- One
- Two
- Three or more
4. How long have you been using eye drops to treat your eye condition?
- Less than 1 week
- 1 to 2 weeks
- 3 or more weeks
5. How many eye drops do not make it into your eye(s) per dose?
- No drops per dose
- 1 to 2 drops per dose
- 3 to 4 drops per dose
- More than 5 drops per dose
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Education/Instructions
Survey Instructions: Please indicate your level of agreement with the
following statements.
1. Instructions on the eye drop box are clear and easy to understand
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5

2. Words used to explain instructions for your eye drops are clear to
understand
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5

3. The use of pictures to illustrate would improve your understanding of the
eye drop instructions.
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5

4. The use of a video demonstration would improve your understanding of
the eye drop instructions.
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5
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Physical/Mechanics
Survey Instructions: Please indicate your level of agreement with the
following statements.

1. Instructions in larger font would improve your ability to see and read the
instructions clearly.
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5

2. Having your health care professional demonstrate how to properly use
your eye drops would improve your ability to use eye drops on your own.
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5

3. An eye drop dispenser tool would improve your ability to properly use
your eye drops.
Strongly
Agree
1

Somewhat
Agree
2

Indifferent
3

Somewhat
Disagree
4

Strongly
Disagree
5
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Open Response Questions
1. What do you believe are educational barriers to effective use (examples of
educational barriers include, but are not limited to complex instructions or
the use of confusing terminology)? In your opinion, how could the
instructions for your eye drops be improved?

2. Do you have any physical limitation that makes using eye drops difficult?
Does this limitation require additional tools or devices to assist in using eye
drops?

3. Does the location of where you instill eye drops (your environment- an
example is your bathroom at home) impact your ability to use them?
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Appendix F: Edina Senior Center Permission
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Appendix G: Burnsville Senior Center Permission
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